EMILY KERNS: Open Payments
NPI 1942845375 · MACON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 37 payments from 22 companies in 2025. Trend: 2023 $614 · 2024 $538 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Viatris Specialty LLC | 3 | $68 |
| ABBVIE INC. | 2 | $61 |
| Novo Nordisk Inc | 3 | $53 |
| Amgen Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
Products named: REXULTI, YUPELRI, UBRELVY, AUSTEDO XR, PREVNAR 20, CAPLYTA, EVENITY, JOURNAVX.
Industry payments across MO — which companies pay providers there.
